Moderna announced today that they have started inoculating children vaccinated in a phased trial.
Called the KidCOVE study, Moderna will enroll 6,750 children in the US and Canada between the ages of 6 months and 11 years old.
Pfizer/BioNTech said they will start children in their trials and J&J also has plans to study the COVID vaccine in teenagers from 12-18.
